The development of oligonucleotide therapeutics continues to accelerate with progress in oligonucleotide chemistry and adoption of delivery technologies. This article will discuss the necessary steps to execute to assure quality of your oligonucleotide APIs and DPs, and compliance with agency expectations.
Antibody-drug conjugates (ADCs) have long been described as a promising component of the industry’s oncology toolkit. The specificity of ADCs has allowed them to meet the growing demand for targeted, safer treatment options for cancer patients. However, their complex nature has led to some challenges when approaching the development and manufacturing of ...
In the EU biocidal products are regulated under the Biocidal Products Regulation (BPR). The BPR requires that products are sufficiently effective against the target organisms that they are intended to control. Efficacy testing of biocidal products is a requirement of product authorisation and a key step in ensuring that products are able to be placed on t ...
RNA therapeutics has evolved tremendously during the las two decades. Eighteen RNA medicines are now on the market, but major challenges still remain. These challenges include finding strategies to enable the use of RNA therapeutics outside the liver in a safe and efficacious manner. This overview summarises the advances that industrial peptide-based nano ...
Although the international scientific definition of probiotics as “live microorganisms that, when administered in adequate amounts, confer a health benefit on the host” is well known, in practice we assist to the frequent misuse of the term ‘probiotic’. IPA Europe’s scientific experts have been working in collaboration with the International Sci ...
According to experts’ views, a digital platform that includes genetic testing, microbiome analysis, lifestyle assessments and actionable personalised recommendations might be the solution for meeting current and future consumers’ demands. This comes with some important challenges to focus on.
Perilla frutescens (L.) extract is used in food supplements to support the immune system and GI comfort. A proprietary Perilla frutescens leaf extract was used to investigate prebiotic effects on strains of Lactobacillus, Bifidobacterium and pathogenic bacteria by testing for growth stimulation effects on agar plates. ... ...
Nutricosmetics business volume keeps on growing, with an expected turnover over 8.5B$ within 2027, registering a CAGR of 5%. Despite of COVID-19 related slow-down of cosmetic market, 2020 gave a push to nutricosmetics one: people have changed their needs indeed, as a result of limitation in pursuing personal goals in term of beauty and well-being. ...
The great challenges facing us today are climate change, geopolitical crises, pandemics, supply chain problems, and reduced biodiversity. The cosmetic industry is adapting to these problems by assuming social responsibility, paying attention to fair trade, and reducing the carbon dioxide footprint. It also considers the need for organic, “green” ingre ...
The cosmetic industry is evolving with the advent of 3D printing, allowing personalization of skincare products. This study investigated how different print design settings affect the hydration performance of hydrogel-based masks. Using an extrusion-based 3D printer, 3-layered gelatin hydrogel occlusive and porous patches were printed and applied on healt ...
In Provital we are globetrotters, we visit the countries where beauty trends and innovations start, we buy and try disruptive products. That’s why we are experts in trends and we can inspire you with the latest hits in the beauty industry. Enjoy the trip with us!!
IOPC represents a great opportunity for exchanging ideas and opinions in the field of peptide and oligonucleotide chemistry and biology with benefit for human health and environment.
Stay at the forefront of OLIGONUCLEOTIDES and PEPTIDES innovation, regulatory and market trends.
Chimica Oggi / Chemistry Today, TKS Publisher, was the first to organize worldwide a conference on the topic CONTINUOUS FLOW REACTOR TECHNOLOGY FOR INDUSTRIAL APPLICATIONS: at a certain point it had a breakthrough in the field of industrial chemical synthesis and Chemistry Today was a pioneer in wide spreading the potentiality in this field. The first event was held in Madrid and showcased the state of the art of this innovative way to produce chemicals. Then after the really big success of this first event, Chemistry Today continued its mission to present real industrial case studies and create a professional networking.
